name: Plasma cell proliferation analysis:Find:Pt:Bone mar:Doc:FISH


name: Triiodothyronine^1st specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Leukocytes:NCnc:Pt:Respiratory system specimen.lower:Qn:Manual count


name: Natural killer cell cytotoxicity.IL-2 stimulated panel:-:Pt:Bld MC:-:Flow cytometry


name: Jewish descent preconception &or prenatal carrier screening multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: CFTR gene & FMR1 gene CGG repeat & SMN1 gene mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Linum usitatissimum seed Ab.IgE:ACnc:Pt:Ser:Qn


name: Bacterial beta-lactam resistance ESBL blaCTX-M-15 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial beta-lactam resistance ESBL blaCTX-M-14 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial carbapenem resistance blaOXA-143 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial colistin resistance mcr-3+mcr-4+mcr-5 genes:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Barmah forest virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Yeast colony^with canavanine glycine+bromothymol blue:Color:Pt:Isolate:Nom:Culture


name: Apis mellifera phospholipase A2 recombinant (rApi m) 1 Ab.IgG4:MCnc:Pt:Ser:Qn


name: HLA-A & B & C (class I) & HLA-DP & DQ & DR (class II) Ab:Prid:Pt:Ser/Plas:Nom


name: Preconception &or prenatal carrier screening multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: SARS coronavirus 2 E gene:ThreshNum:Pt:Respiratory System Specimen:Qn:Probe.amp.tar


name: PCNA extractable nuclear Ab:Titr:Pt:CSF:SemiQn:IF


name: Reduction in clot strength.kaolin induced^30M post maximum clot amplitude:LenFr:Pt:Bld:Qn:Thromboelastography.resonance


name: Acinetobacter calcoaceticus-baumannii complex DNA:PrThr:Pt:Bld.pos growth:Ord:Non-probe.amp.tar


name: Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA:PrThr:Pt:Genital:Ord:Probe.amp.sig


name: Yersinia outer protein H Ab:PrThr:Pt:Ser:Ord:Line blot


name: Parvimonas micra DNA:PrThr:Pt:Synv fld:Ord:Non-probe.amp.tar


name: Parainfluenza virus 1+2+3+4 RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: (Alternaria alternata+Cladosporium herbarum+Mucor racemosus+Penicillium notatum) Ab.IgG:MCnc:Pt:Ser:Qn:Multidisk


name: Counselor/Therapist (certified or licensed)


name: Health Education - Large Group (13 or more)


name: Public health provider - public health clinic


name: Long-term care - nursing home, skilled nursing facility, federally certified


name: Public health provider - Federally Qualified Health Center


name: Public health provider - Rural Health Clinic


name: Long-term care - nursing home, skilled nursing facility, non-federally certified


name: Long-term care - intellectual or developmental disability


name: Other family members (e.g., aunt, uncle, cousin)


name: Vertebral body replacement by auto-/allograft


name: Would like help finding daycare for child:Find:Pt:^Caregiver:Ord


name: Always has enough food for family:Find:Pt:^Caregiver:Ord


name: At risk of having utilities shut off in the next week:Find:Pt:^Caregiver:Ord


name: Trouble paying heating bill &or electricity bill:Find:Pt:^Caregiver:Ord


name: Needs help getting food for family for tonight:Find:Pt:^Caregiver:Ord


name: Would like help getting food for family:Find:Pt:^Caregiver:Ord


name: Emergent risk of becoming homeless:Find:Pt:^Caregiver:Ord


name: Would like help for being at risk of becoming homeless:Find:Pt:^Caregiver:Ord


name: At risk of becoming homeless:Find:Pt:^Caregiver:Ord


name: Needs daycare for child:Find:Pt:^Caregiver:Ord


name: Would like help finding employment &or job training:Find:Pt:^Caregiver:Ord


name: Would like help to get a GED:Find:Pt:^Caregiver:Ord


name: WE CARE Survey:-:Pt:^Caregiver:-:WE CARE


name: LACE index score:Score:Pt:^Patient:Qn:LACE index


name: Intervention or enabling service minutes:Num:Pt:^Patient:Qn


name: Association of Asian Pacific Community Health Organizations enabling services and social intervention panel:-:Pt:^Patient:-:AAPCHO


name: Would like help with paying heating &or electricity bill:Find:Pt:^Caregiver:Ord


name: Service integration total score:Score:Pt:^Patient:Qn:R-Outcomes


name: Accountable health communities health-related social needs screening tool:-:Pt:^Patient:-


name: Coronavirus racial bias scale:-:Pt:^Patient:-:CRBS


name: Due to the coronavirus I have been cyberbullied because of my race or ethnicity:Find:Pt:^Patient:Ord:CRBS


name: Since the coronavirus I have seen a lot more cyberbullying of people of my race or ethnicity:Find:Pt:^Patient:Ord:CRBS


name: Tobacco, Alcohol, Prescription medications, and other Substance use screen:-:12Mo:^Patient:-:TAPS


name: How often have you used any prescription medications just for the feeling, more than prescribed or that were not prescribed for you in past 12Mo:NRat:12Mo:^Patient:Ord:TAPS


name: Tobacco, Alcohol, Prescription medications, and other Substance use assessment:-:3Mo:^Patient:-:TAPS


name: Have you tried and failed to control, cut down or stop drinking in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Has anyone expressed concern about your drinking in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Have you had a strong desire or urge to use marijuana at least once a week or more often in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Has anyone expressed concern about your use of marijuana in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Has anyone expressed concern about your use of cocaine, crack, or methamphetamine in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Have you tried and failed to control, cut down or stop using heroin in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Has anyone expressed concern about your use of heroin in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Have you tried and failed to control, cut down or stop using an opiate pain reliever in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Has anyone expressed concern about your use of an opiate pain reliever in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Have you had a strong desire or urge to use medications for anxiety or sleep at least once a week or more often in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Has anyone expressed concern about your use of medication for anxiety or sleep in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Has anyone expressed concern about your use of a medication for ADHD in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: Used other illegal or recreational drug in past 3Mo:Find:3Mo:^Patient:Ord:TAPS


name: I believe the country has become more dangerous for people in my racial or ethnic group because of fear of the coronavirus:Find:Pt:^Patient:Ord:CRBS


name: People of my race or ethnicity are more likely to lose their job because of the coronavirus:Find:Pt:^Patient:Ord:CRBS


name: I worry about people thinking I have the coronavirus simply because of my race or ethnicity:Find:Pt:^Patient:Ord:CRBS


name: Most social and mass media reports about the coronavirus create bias against people of my racial or ethnic group:Find:Pt:^Patient:Ord:CRBS


name: People of my race or ethnicity are more likely to get the coronavirus:Find:Pt:^Patient:Ord:CRBS


name: People of my race or ethnicity will not receive coronavirus healthcare as good as the care received by other groups:Find:Pt:^Patient:Ord:CRBS


name: Negative social media posts against people of my race or ethnicity have increased because of the coronavirus:Find:Pt:^Patient:Ord:CRBS


name: MDS v3.0 - RAI v1.17.2 - Delirium:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Hearing, speech, and vision - NC, NP, NQ, SP:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Cognitive patterns - NC, NP, NQ, SP:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Bladder and bowel - NC:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Bladder and bowel - ND, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Bladder and bowel - NP, NQ, SP:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Cognitive patterns - ND, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Staff assessment for mental status:-:RptPeriod:^Patient:-:CMS Assessment


name: Average diameter on axial mid-scan image:Len:Pt:^Patient:Qn:CT


name: Average diameter on frontal scout image:Len:Pt:^Patient:Qn:CT


name: Social determinants of health panel:-:Pt:^Patient:-:R-Outcomes


name: Social determinants of health score:Score:Pt:^Patient:Qn:R-Outcomes


name: Carbon dioxide^at end expiration-Carbon dioxide^at end expiration+W sub-maximal exercise:PPresDiff:Pt:Exhl gas:Qn


name: Test result delivery method:Type:Pt:Referral lab test:Nom


name: Vaccine doses distributed/100,000 population:NRto:Pt:^Event:Qn


name: People who have received first dose of vaccine:Num:Pt:^Population:Qn


name: People who have received first dose of vaccine/100,000 population:NFr:Pt:^Population:Qn


name: People who are fully vaccinated:Num:Pt:^Population:Qn


name: People who are fully vaccinated/100,000 population:NFr:Pt:^Population:Qn


name: Vaccine doses distributed for use in long term care facilities:Num:Pt:^Event:Qn


name: People in long-term care facilities who have received first dose of vaccine:Num:Pt:^Population:Qn


name: People in long-term care facilities who are fully vaccinated:Num:Pt:^Population:Qn


name: Accountable health communities health-related social needs supplemental questions:-:Pt:^Patient:-


name: Spine Tango surgery follow-up 2017:-:Pt:^Patient:-:Spine Tango


name: Finnish diabetes risk score panel:-:Pt:^Patient:-:FINDRISC


name: Chronic diseases &or immunodeficiency:Hx:Pt:^Patient:Ord


name: Coagulation disorder &or blood-thinning medication use:Hx:Pt:^Patient:Ord


name: COVID-19 experiences - media use panel:-:Pt:^Patient:-:COVEX


name: Colonoscopy and endoscopic ultrasound study:Find:Pt:Lower GI tract:Doc:Colonoscopy+US


name: Flexible sigmoidoscopy and endoscopic ultrasound study:Find:Pt:Lower GI tract:Doc:Flexible sigmoidoscopy+US


name: Person who lost job or income due to COVID-19 outbreak:Find:Pt:^Household member:Nom


name: COVID-19 experiences - employment and school changes panel:-:Pt:^Patient:-:COVEX


name: COVID-19 experiences - coping panel:-:Pt:^Patient:-:COVEX


name: Core Outcome Measures Index for the Neck:-:Pt:^Patient:-:COMI


name: How much did health condition interfere with normal work in past W:Find:1W:^Patient:Ord


name: View AP external rotation:Find:Pt:Upper extremity.right>Shoulder:Doc:XR


name: View AP internal rotation:Find:Pt:Upper extremity.right>Shoulder:Doc:XR


name: View AP external rotation:Find:Pt:Upper extremity>Shoulder:Doc:XR


name: View AP internal rotation:Find:Pt:Upper extremity>Shoulder:Doc:XR


name: Views AP + oblique:Find:Pt:Chest>Clavicle.bilateral:Doc:XR


name: View AP external rotation:Find:Pt:Upper extremity.left>Shoulder:Doc:XR


name: View AP internal rotation:Find:Pt:Upper extremity.left>Shoulder:Doc:XR


name: Views lateral^W manual stress:Find:Pt:Upper extremity.bilateral>Elbow:Doc:XR


name: Views lateral^W manual stress:Find:Pt:Upper extremity.left>Elbow:Doc:XR


name: Views lateral^W manual stress:Find:Pt:Upper extremity.right>Elbow:Doc:XR


name: Multisection^WO & W contrast IV:Find:Pt:Abdomen+Pelvis:Doc:MR


name: Guidance for injection:Find:Pt:Upper extremity.left>Elbow:Doc:US


name: Guidance for injection:Find:Pt:Upper extremity.right>Elbow:Doc:US


name: Guidance for injection:Find:Pt:Upper extremity.bilateral>Elbow:Doc:US


name: Views AP + lateral:Find:Pt:Upper extremity.left>Finger.third:Doc:XR


name: Views AP + lateral:Find:Pt:Upper extremity.left>Finger.second:Doc:XR


name: Views AP + lateral:Find:Pt:Upper extremity.left>Finger.fourth:Doc:XR


name: Views AP + lateral:Find:Pt:Upper extremity.left>Finger.fifth:Doc:XR


name: Views AP + lateral:Find:Pt:Upper extremity.right>Finger.fourth:Doc:XR


name: Views AP + lateral:Find:Pt:Upper extremity.right>Finger.fifth:Doc:XR


name: Views AP + lateral:Find:Pt:Upper extremity.right>Finger.second:Doc:XR


name: Views AP + lateral:Find:Pt:Upper extremity.right>Finger.third:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.left>Toe.fifth:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.left>Toe.fourth:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.left>Toe.third:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.left>Toe.second:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.left>Great toe:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.left>Toe.third:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.left>Toe.fourth:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.left>Toe.second:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.left>Toe.fifth:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.left>Great toe:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.right>Toe.third:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.right>Toe.second:Doc:XR


name: View AP:Find:Pt:Lower extremity.bilateral>Great toe:Doc:XR


name: View oblique:Find:Pt:Lower extremity.bilateral>Great toe:Doc:XR


name: View lateral:Find:Pt:Lower extremity.bilateral>Great toe:Doc:XR


name: view oblique:Find:Pt:Lower extremity.left>Great toe:Doc:XR


name: View lateral:Find:Pt:Lower extremity.left>Great toe:Doc:XR


name: View AP:Find:Pt:Lower extremity.left>Great toe:Doc:XR


name: View AP:Find:Pt:Lower extremity.right>Great toe:Doc:XR


name: View lateral:Find:Pt:Lower extremity.right>Great toe:Doc:XR


name: View oblique:Find:Pt:Lower extremity.right>Great toe:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.right>Toe.fifth:Doc:XR


name: Views AP + lateral + oblique:Find:Pt:Lower extremity.right>Toe.fourth:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.right>Toe.third:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.right>Great toe:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.right>Toe.second:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.right>Toe.fourth:Doc:XR


name: Views AP + lateral:Find:Pt:Lower extremity.right>Toe.fifth:Doc:XR


name: Progress note:Find:Pt:{Setting}:Doc:Cardiovascular disease+Pulmonary disease


name: Progress note:Find:Pt:{Setting}:Doc:Colon and rectal surgery


name: Progress note:Find:Pt:{Setting}:Doc:Surgery of the hand


name: Progress note:Find:Pt:{Setting}:Doc:Heart failure+Transplant cardiology


name: Predicted response to cancer treatment:Find:Pt:^Patient:Ord:Based on lab data


name: Admission history and physical note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Evaluation note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Discharge instructions:Find:Pt:Emergency department:Doc:Emergency medicine


name: Discharge summary note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Discharge teaching note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Education note:Find:Pt:Emergency department:Doc:Emergency medicine


name: History and physical note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Initial evaluation note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Procedure note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Progress note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Transfer summary note:Find:Pt:Emergency department:Doc:Emergency medicine


name: Triage note:Find:Pt:Emergency department:Doc:Emergency medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Interventional cardiology


name: History and physical note:Find:Pt:{Setting}:Doc:Interventional radiology


name: History and physical note:Find:Pt:{Setting}:Doc:Pulmonary disease


name: History and physical note:Find:Pt:{Setting}:Doc:Oral and maxillofacial surgery


name: History and physical note:Find:Pt:{Setting}:Doc:Anesthesiology


name: History and physical note:Find:Pt:{Setting}:Doc:Burn management


name: History and physical note:Find:Pt:{Setting}:Doc:Colon and rectal surgery


name: History and physical note:Find:Pt:{Setting}:Doc:Nutrition and dietetics


name: History and physical note:Find:Pt:{Setting}:Doc:Infectious disease


name: History and physical note:Find:Pt:{Setting}:Doc:Nurse


name: History and physical note:Find:Pt:{Setting}:Doc:Pharmacology


name: History and physical note:Find:Pt:{Setting}:Doc:Radiation oncology


name: History and physical note:Find:Pt:{Setting}:Doc:Radiology


name: History and physical note:Find:Pt:{Setting}:Doc:Rheumatology


name: History and physical note:Find:Pt:{Setting}:Doc:Trauma


name: Discharge summary note:Find:Pt:{Setting}:Doc:Interventional cardiology


name: Surgical operation note:Find:Pt:{Setting}:Doc:Interventional radiology


name: Evaluation note:Find:Pt:{Setting}:Doc:Maternal and fetal medicine


name: Evaluation note:Find:Pt:{Setting}:Doc:Solid organ transplant


name: Discharge summary note:Find:Pt:{Setting}:Doc:Burn management


name: Discharge summary note:Find:Pt:{Setting}:Doc:Gynecologic oncology


name: Discharge summary note:Find:Pt:{Setting}:Doc:Maternal and fetal medicine


name: Discharge summary note:Find:Pt:{Setting}:Doc:Oral and maxillofacial surgery


name: Discharge summary note:Find:Pt:{Setting}:Doc:Radiation oncology


name: Surgical operation note:Find:Pt:{Setting}:Doc:Gynecologic oncology


name: Procedure note:Find:Pt:{Setting}:Doc:Solid organ transplant


name: Evaluation note:Find:Pt:{Setting}:Doc:Surgery of the hand


name: Discharge summary note:Find:Pt:{Setting}:Doc:Surgery of the hand


name: History and physical note:Find:Pt:{Setting}:Doc:Surgery of the hand


name: Procedure note:Find:Pt:{Setting}:Doc:Surgery of the hand


name: Surgical operation note:Find:Pt:{Setting}:Doc:Surgery of the hand


name: History and physical note:Find:Pt:{Setting}:Doc:Hepatology


name: History and physical note:Find:Pt:{Setting}:Doc:Hematology


name: Discharge summary note:Find:Pt:{Setting}:Doc:Sleep medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Sleep medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Occupational therapy


name: History and physical note:Find:Pt:{Setting}:Doc:Recreational therapy


name: History and physical note:Find:Pt:{Setting}:Doc:Respiratory therapy


name: Admission or pathology panel:-:Pt:^Patient:-:Spine Tango


name: Specification of main pathology panel:-:Pt:^Patient:-:Spine Tango


name: Surgical measures panel:-:Pt:^Patient:-:Spine Tango


name: Motion preserving spine stablization:Type:Pt:^Patient:Nom


name: Hospital stay panel:-:Pt:^Patient:-:Spine Tango


name: Stay Independent panel:-:Pt:^Patient:-:Stay Independent


name: Stay Independent total score:Score:Pt:^Patient:Qn:Stay Independent


name: Core Outcome Measures Index for the Neck score:Score:Pt:^Patient:Qn:COMI


name: Core Outcome Measures Index for the Back:-:Pt:^Patient:-:COMI


name: Core Outcome Measures Index for the Back score:Score:Pt:^Patient:Qn:COMI


name: Oswestry disability index score:Score:Pt:^Patient:Qn:ODI


name: Body weight.current fetus/Body weight.heaviest fetus:MRto:Pt:^Fetuses:Qn:US+Calculated


name: Multisection^W radionuclide IV:Find:Pt:Lower extremity:Doc:PT+CT


name: Views for therapy^W Tc-99m SC IV:Find:Pt:Abdomen:Doc:NM


name: Urothelial carcinoma recurrence score:Score:Pt:Urine:Qn:Molgen


name: XR|Elbow|Views lateral^W manual stress|Laterality:ANY


name: XR|Finger.fifth|Views AP + lateral|Laterality:ANY


name: XR|Finger.fourth|Views AP + lateral|Laterality:ANY


name: XR|Finger.second|Views AP + lateral|Laterality:ANY


name: XR|Finger.third|Views AP + lateral|Laterality:ANY


name: XR|Great toe|Views AP + lateral|Laterality:ANY


name: XR|Shoulder|View AP external rotation|Laterality:ANY


name: XR|Shoulder|View AP internal rotation|Laterality:ANY


name: XR|Toe.fifth|Views AP + lateral + oblique|Laterality:ANY


name: XR|Toe.fifth|Views AP + lateral|Laterality:ANY


name: XR|Toe.fourth|Views AP + lateral + oblique|Laterality:ANY


name: XR|Toe.fourth|Views AP + lateral|Laterality:ANY


name: XR|Toe.second|Views AP + lateral + oblique|Laterality:ANY


name: XR|Toe.second|Views AP + lateral|Laterality:ANY


name: XR|Toe.third|Views AP + lateral|Laterality:ANY


name: 2,3-dinor 11 beta-Prostaglandin F2 alpha/Creatinine|MRto|Urine


name: XR|Toe.third|Views AP + lateral + oblique|Laterality:ANY


name: at end expiration+W sub-maximal exercise


name: Carbon dioxide^at end expiration-Carbon dioxide^at end expiration+W sub-maximal exercise


name: Total doses distributed per 100,000 population


name: Clot stiffness.fibrinogen contribution.tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited^post heparin neutralization


name: Coagulation dilute Russell viper venom induced/Coagulation dilute Russell viper venom induced.excess phospholipid^^normalized


name: Coagulation dilute Russell viper venom induced/Coagulation dilute Russell viper venom induced.excess phospholipid^post DOAC neutralization^normalized


name: Blood flow velocity.max.stenosis.internal carotid artery


name: HIV ART actual prescription fills number


name: Intravascular systolic.posterior tibial artery


name: Volume at 25-75% of forced expiration.measured


name: Nucleic acid amplification using Centers for Disease Control and Prevention primer-probe set N3


name: Anaplasma marginale Ab/Negative control | Serum | Microbiology


name: Bordetella avium Ab/Positive control | Serum | Microbiology


name: Mycobacterium avium subspecies paratuberculosis Ab/Positive control | XXX | Microbiology


name: Mycoplasma gallisepticum Ab/Positive control | Serum | Microbiology


name: Mycoplasma hyorhinis Ab.IgG/Positive control | Serum | Microbiology


name: Mycoplasma synoviae Ab/Positive control | Serum | Microbiology


name: Salmonella choleraesuis+infantis+typhimurium Ab/Positive control | XXX | Microbiology


name: Yersinia outer protein Ab band pattern | Serum | Microbiology


name: Blastomyces sp Ab band pattern | XXX | Microbiology


name: Coccidioides sp Ab band pattern | XXX | Microbiology


name: Histoplasma capsulatum mycelial phase Ab band pattern | XXX | Microbiology


name: Paracoccidioides sp Ab band pattern | XXX | Microbiology


name: Neospora caninum Ab/Negative control | Serum | Microbiology


name: Avian encephalomyelitis virus Ab/Positive control | Serum | Microbiology


name: Avian paramyxovirus 1 Ab/Positive control | Serum | Microbiology


name: Avian metapneumovirus Ab/Positive control | Serum | Microbiology


name: Avian reovirus Ab/Positive control | Serum | Microbiology


name: Bluetongue virus Ag/Negative control | Serum | Microbiology


name: Bovine diarrhea virus Ag/Positive control | XXX | Microbiology


name: Infectious bronchitis virus Ab/Positive control | Serum | Microbiology


name: Infectious bursal disease virus Ab/positive control | Serum | Microbiology


name: West Nile virus Ab.IgM/Positive control | Serum | Microbiology


name: Anticomplementary activity | XXX | Microbiology


name: GISAID sequence accession number | Isolate | Microbiology


name: Medium induced in vitro yeast conversion | Isolate | Microbiology


name: Microorganism of interest sequence | XXX | Microbiology


name: Sequencing study identifier | Specimen | Microbiology


name: Texture.yeast colony | Isolate | Microbiology


name: Thermotolerance | Isolate | Microbiology


name: Acanthamoeba sp and Naegleria fowleri and Balamuthia mandrillaris DNA panel | XXX | Microbiology Panels


name: Chikungunya virus Ab.IgM and IgG panel | Serum or Plasma | Microbiology Panels


name: Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel | Anorectal | Microbiology Panels


name: Fungal Ab panel | XXX | Microbiology Panels


name: Hantavirus IgG and IgM panel | Serum or Plasma | Microbiology Panels


name: Herpes virus 8 IgG and IgM panel | Serum or Plasma | Microbiology Panels


name: HIV 1 Ab panel | Serum or Plasma | Microbiology Panels


name: HIV 2 Ab panel | Serum or Plasma | Microbiology Panels


name: Influenza virus A and B Ag panel | Upper respiratory specimen | Microbiology Panels


name: Influenza virus A and B and SARS-CoV-2 (COVID-19) Ag panel | Upper respiratory specimen | Microbiology Panels


name: Influenza virus types A and B and subtypes RNA panel | XXX | Microbiology Panels


name: Joint pathogens panel | Synovial fluid | Microbiology Panels


name: Parainfluenza virus 1 and 2 and 3 Ab panel | Serum or Plasma | Microbiology Panels


name: Rabies virus Ab panel | Serum or Plasma | Microbiology Panels


name: SARS-CoV-2 (COVID-19) RNA panel | Oropharyngeal wash | Microbiology Panels


name: SARS-CoV-2 (COVID-19) sequencing and identification panel | XXX | Microbiology Panels


name: SARS-CoV-2 stimulated gamma interferon panel | Blood | Microbiology Panels


name: Yellow fever virus Ab panel | Serum or Plasma | Microbiology Panels


name: Yersinia outer protein Ab panel | Serum | Microbiology Panels


name: Zika virus Ab panel | Serum or Plasma | Microbiology Panels


name: Moxifloxacin 3.0 ug/mL | Isolate | Antibiotic susceptibilities


name: Carbapenem resistant bacteria identification and resistance panel | Isolate or Specimen | Antibiotic Susceptibility Panels


name: Staphylococcus aureus identification and resistance panel | Isolate or Specimen | Antibiotic Susceptibility Panels


name: Phosphatidylethanolamine/Surfactants.total | Amniotic fluid | Chemistry - non-challenge


name: Amylase.fld/Amylase.serum | Bodyfluid and Serum or Plasma | Chemistry - non-challenge


name: Lactate dehydrogenase.pericard fld/Lactate dehydrogenase.serum | Pericardial fluid and serum or plasma | Chemistry - non-challenge


name: Lactate dehydrogenase.periton fld/Lactate dehydrogenase.serum | Peritoneal fluid and serum or plasma | Chemistry - non-challenge


name: Lactate dehydrogenase.plr fld/Lactate dehydrogenase.serum | Serum or Plasma and Pleural fluid | Chemistry - non-challenge


name: Carboxyhemoglobin/Hemoglobin.total | Blood central venous | Chemistry - non-challenge


name: Oxygen content | Blood central venous | Chemistry - non-challenge


name: SaO2 | Blood central venous | Chemistry - non-challenge


name: Methemoglobin/Hemoglobin.total | Blood central venous | Chemistry - non-challenge


name: Oxyhemoglobin/Hemoglobin.total | Blood central venous | Chemistry - non-challenge


name: pH | Blood central venous | Chemistry - non-challenge


name: Adenosine/Creatinine | Urine | Chemistry - non-challenge


name: Crotonylglycine/Creatinine | Urine | Chemistry - non-challenge


name: Glycine CSF:Pl | Plasma and CSF | Chemistry - non-challenge


name: Glycine Pl:CSF | Plasma and CSF | Chemistry - non-challenge


name: Albumin.CSF/Albumin.SerPl | Serum or Plasma and CSF | Chemistry - non-challenge


name: Albumin.pericard fld/Albumin.SerPl | Pericardial fluid and serum or plasma | Chemistry - non-challenge


name: Albumin.periton fld/Albumin.SerPl | Peritoneal fluid and serum or plasma | Chemistry - non-challenge


name: Albumin.serum/Albumin.Periton fld | Peritoneal fluid and serum or plasma | Chemistry - non-challenge


name: Retinol binding protein/Creatinine | Urine | Chemistry - non-challenge


name: Beta-2-Microglobulin.CSF/Beta-2-Microglobulin.serum | Serum and CSF | Chemistry - non-challenge


name: IgA.CSF/IgA.serum | Serum and CSF | Chemistry - non-challenge


name: IgG.CSF/IgG.serum | Serum and CSF | Chemistry - non-challenge


name: IgM.CSF/IgM.serum | Serum and CSF | Chemistry - non-challenge


name: Prot CSF:SerPl | Serum and CSF | Chemistry - non-challenge


name: Prot Plr:SerPl | Serum or Plasma and Pleural fluid | Chemistry - non-challenge


name: Protein/Osmolality | Urine | Chemistry - non-challenge


name: Radioactive iodine.thyroid/Radioactive iodine.dose | Thyroid | Chemistry - non-challenge


name: 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2/24,25-dihydroxyvitamin D3+24,25-dihydroxyvitamin D2 | Serum or Plasma | Chemistry - non-challenge


name: Chenodeoxycholate+Cholate/Bile acid.total | Stool | Chemistry - non-challenge


name: Creatinine dial fld/Creatinine ser_plas | Dialysis fluid + Serum or Plasma | Chemistry - non-challenge


name: Glomerular filtration rate/Body surface area | Serum or Plasma | Chemistry - non-challenge


name: Glucose management indicator | Interstitial fluid | Chemistry - non-challenge


name: Glucose measurements in range/Total glucose measurements | Interstitial fluid | Chemistry - non-challenge


name: Glucose standard deviation | Interstitial fluid | Chemistry - non-challenge


name: Glucose CSF:SerPl | Plasma and CSF | Chemistry - non-challenge


name: 4-hydroxyglutamate/Creatinine | Urine | Chemistry - non-challenge


name: N-acetylgalactosamine-4-sulfatase/N-acetylgalactosamine-6-sulfatase | Urine | Chemistry - non-challenge


name: N-Nervonoylsphingosine/N-Lignoceroylsphingosine | Plasma | Chemistry - non-challenge


name: N-Palmitoylsphingosine/N-Lignoceroylsphingosine | Plasma | Chemistry - non-challenge


name: N-Stearoylsphingosine/N-Lignoceroylsphingosine | Plasma | Chemistry - non-challenge


name: 2-Octenoate/Creatinine | Urine | Chemistry - non-challenge


name: Lysosomal storage disorders newborn screening comment/discussion | DBS | Chemistry - non-challenge


name: Osmolality ur:ser | Urine and Serum or Plasma | Chemistry - non-challenge


name: Dermatan sulfate/Creatinine | Urine | Chemistry - non-challenge


name: Heparan sulfate/Creatinine | Urine | Chemistry - non-challenge


name: Keratan sulfate/Creatinine | Urine | Chemistry - non-challenge


name: Magnesium SerPl:RBC | Blood | Chemistry - non-challenge


name: Magnesium cutoff | Stool | Chemistry - non-challenge


name: Phosphate cutoff | Stool | Chemistry - non-challenge


name: Alpha-1-Fetoprotein.L3/Alpha-1-Fetoprotein.total | Serum or Plasma | Chemistry - non-challenge


name: 2-Decenedioate/Creatinine | Urine | Chemistry - non-challenge


name: Gamma hydroxybutyrate cutoff | Serum or Plasma | Chemistry - non-challenge


name: 2,3-dinor 11 beta-Prostaglandin F2 alpha/Creatinine | Urine | Chemistry - non-challenge


name: Heptacarboxylporphyrin I/Creatinine | Urine | Chemistry - non-challenge


name: Hexacarboxylporphyrin I/Creatinine | Urine | Chemistry - non-challenge


name: Pentacarboxylporphyrin I/Creatinine | Urine | Chemistry - non-challenge


name: Rivalta test | Body fluid | Chemistry - non-challenge


name: Carnitine free and total and acylcarnitine panel | Serum or Plasma | Chemistry Panels


name: Cobalamins and folate panel | Serum | Chemistry Panels


name: Delta aminolevulinate and porphobilinogen panel | Serum or Plasma | Chemistry Panels


name: Gas panel | Blood central venous | Chemistry Panels


name: Glial fibrillary acidic protein and Ubiquitin carboxyl-terminal hydrolase-L1 panel | Plasma | Chemistry Panels


name: Magnesium and phosphate and lactate panel | Serum or Plasma | Chemistry Panels


name: Prion disease biomarker panel | Cerebral spinal fluid | Chemistry Panels


name: Cortisol, glucose, and somatotropin post arginine stimulation panel | Serum or Plasma | Challenge Bank Panels


name: Somatotropin post glucose stimulation panel | Serum or Plasma | Challenge Bank Panels


name: Copper.free/Copper.total | Serum or Plasma | Drug toxicology


name: Gadolinium/Creatinine | Urine | Drug toxicology


name: Cannabidiol/Tetrahydrocannabinol | Urine | Drug toxicology


name: Norbuprenorphine cutoff | Saliva | Drug toxicology


name: Norbuprenorphine cutoff | Urine | Drug toxicology


name: Norbuprenorphine/Creatinine | Urine | Drug toxicology


name: Cenobamate | Serum or Plasma | Drug toxicology


name: Muscle relaxants | Saliva | Drug toxicology


name: Busulfan clearance | Plasma | Drug toxicology


name: Lithium SerPl:RBC | Blood | Drug toxicology


name: Lithium Sal:Ser:Pl | Serum and Saliva | Drug toxicology


name: Amphetamines panel | Urine | Drug and Toxicology Panels


name: Mephobarbital and PHENobarbital panel | Serum or Plasma | Drug and Toxicology Panels


name: Plasma cells.polyclonal/Cells counted | Bone marrow | Hematology and Cell counts


name: Clot initiation.kaolin induced/Clot initiation.kaolin induced | Blood | Coagulation


name: Endogenous thrombin potential | Platelet poor plasma | Coagulation


name: Time to thrombin peak | Platelet poor plasma | Coagulation


name: Coagulation factor X activated actual/Normal | Platelet poor plasma | Coagulation


name: aPTT mixing study panel | Platelet poor plasma | Coagulation Panels


name: Clot formation and Platelet function.glass bead induced panel | Blood | Coagulation Panels


name: Clot formation and Platelet function.glass bead induced post heparin neutralization panel | Blood | Coagulation Panels


name: Clot formation.diatomaceous earth induced panel | Blood | Coagulation Panels


name: Clot formation.diatomaceous earth+clay induced panel | Blood | Coagulation Panels


name: Clot formation.glass bead induced panel | Blood | Coagulation Panels


name: Clot formation.kaolin induced panel | Blood | Coagulation Panels


name: Phosphatidylserine-prothrombin complex IgG and IgM panel | Serum or Plasma | Coagulation Panels


name: Thrombin generation test panel | Platelet poor plasma | Coagulation Panels


name: Cells.CD3+CD4+/Cells.CD3+CD8+ | Lower respiratory specimen | Cell markers


name: Lymphocyte T-cell and B-cell and Natural killer subsets panel | Lower respiratory specimen | Cellmarker Panels


name: Natural killer cell cytotoxicity.IL-2 stimulated panel | Blood mononuclear cells | Cellmarker Panels


name: GenBank sequence accession number | Isolate | Molecular pathology


name: Chromosome analysis | Products of Conception | Molecular pathology


name: ABCD1 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: ACADM gene full mutation analysis | Blood or Tissue | Molecular pathology


name: ACADS gene full mutation analysis | Blood or Tissue | Molecular pathology


name: AGXT gene deletion+duplication and full mutation analysis | Blood or Tissue | Molecular pathology


name: APC gene deletion+duplication and full mutation analysis | Blood or Tissue | Molecular pathology


name: ATP7B gene full mutation analysis | Blood or Tissue | Molecular pathology


name: BMPR1A gene deletion+duplication & full mutation analysis | Blood or Tissue | Molecular pathology


name: BRCA1+BRCA2 gene deletion+duplication and full mutation analysis | Blood or Tissue | Molecular pathology


name: BTD gene full mutation analysis | Blood or Tissue | Molecular pathology


name: BTK gene full mutation analysis | Blood or Tissue | Molecular pathology


name: CARD11 gene targeted mutation analysis | Blood or Tissue | Mutations


name: CD79A gene targeted mutation analysis | Blood or Tissue | Mutations


name: CD79B gene targeted mutation analysis | Blood or Tissue | Mutations


name: CDH1 gene deletion+duplication and full mutation analysis | Blood or Tissue | Molecular pathology


name: CFTR and FMR1 (CGG repeat) and SMN1 gene mutation analysis | Blood or Tissue | Molecular pathology


name: CPT2 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: CSF3R gene exons 14 and 17 targeted mutation analysis | Blood or Tissue | Mutations


name: CYP21A2 gene deletion+duplication and full mutation analysis | Blood or Tissue | Molecular pathology


name: EZH2 gene targeted mutation analysis | Blood or Tissue | Mutations


name: F2 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: F5 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: F7 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: F8 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: F9 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: F10 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: F11 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: F12 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: FECH gene full mutation analysis | Blood or Tissue | Molecular pathology


name: FLCN gene deletion+duplication and full mutation analysis | Blood or Tissue | Molecular pathology


name: FLT3 gene internal tandem duplication/normal | Blood or Tissue | Mutations


name: G6PD gene full mutation analysis | Blood or Tissue | Molecular pathology


name: GBA gene full mutation analysis | Blood or Tissue | Molecular pathology


name: Gene XXX mutation analysis limited to known familial mutations | Blood or Tissue | Molecular pathology


name: GJB1 gene deletion+duplication & full mutation analysis | Blood or Tissue | Mutations


name: GRHPR gene deletion+duplication and full mutation analysis | Blood or Tissue | Molecular pathology


name: MDM2 gene copy number/Chromosome 12 copy number | Tissue and Smears | Molecular pathology


name: MDM2 gene copy number/nucleus | Tissue and Smears | Molecular pathology


name: MECP2 gene deletion+duplication and full mutation analysis | Blood or Tissue | Molecular pathology


name: MET gene copy number/Chromosome 7 copy number | Blood or Tissue | Molecular pathology


name: MET gene copy number/nucleus | Blood or Tissue | Molecular pathology


name: MLH1 gene methylation analysis | Blood | Molecular pathology


name: MLH1 gene methylation analysis | Tumor | Molecular pathology


name: MLH1 gene deletion+duplication and full mutation analysis | Blood or Tissue | Molecular pathology


name: MSH2 gene deletion+duplication & full mutation analysis | Blood or Tissue | Molecular pathology


name: MSH6 gene deletion+duplication & full mutation analysis | Blood or Tissue | Molecular pathology


name: MUTYH gene full mutation analysis | Blood or Tissue | Molecular pathology


name: MYCN gene copy number/nucleus | Tissue and Smears | Molecular pathology


name: MYCN gene copy number/Chromosome 2 copy number | Tissue and Smears | Molecular pathology


name: MYD88 gene targeted mutation analysis | Blood or Tissue | Mutations


name: PKHD1 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: PKLR gene deletion+duplication and full mutation analysis | Blood or Tissue | Molecular pathology


name: PROS1 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: PRSS1 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: PTEN gene deletion+duplication and full mutation analysis | Blood or Tissue | Molecular pathology


name: RET gene full mutation analysis | Blood or Tissue | Molecular pathology


name: SERPINA1 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: SERPINC1 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: SMN1 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: SMN2 gene copy number | Blood or Tissue | Molecular pathology


name: SPINK1 gene full mutation analysis | Blood or Tissue | Molecular pathology


name: STK11 gene deletion+duplication and full mutation analysis | Blood or Tissue | Molecular pathology


name: TNFAIP3 gene targeted mutation analysis | Blood or Tissue | Mutations


name: TP53 gene deletion+duplication and full mutation analysis | Blood or Tissue | Molecular pathology


name: TTR gene full mutation analysis | Blood or Tissue | Molecular pathology


name: UBE3A gene full mutation analysis | Blood or Tissue | Molecular pathology


name: VWF gene full mutation analysis | Blood or Tissue | Molecular pathology


name: B-cell primary immunodeficiency multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary breast and gynecologic cancer multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary cancer multigene analysis | Blood or Tissue | Molecular pathology


name: Jewish descent preconception AndOr prenatal carrier screening multigene analysis | Blood or Tissue | Molecular pathology


name: Preconception AndOr prenatal carrier screening multigene analysis | Blood or Tissue | Molecular pathology


name: Comment on overall fetal aneuploidy risk | Plasma cell-free+WBC DNA | Molecular pathology


name: Plasma cell proliferation analysis | Bone marrow | Molecular pathology


name: Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel | Plasma cell-free+WBC DNA | Molecular Pathology Panels


name: Noninvasive prenatal fetal aneuploidy panel | Plasma cell-free+WBC DNA | Molecular Pathology Panels


name: Anterior surgical resection | Lower GI tract | Pathology


name: Prostate tumor area with Gleason pattern 4+5/Total tumor area | Prostate tumor | Pathology


name: Intercellular bridge nuclear Ab pattern | Cerebral spinal fluid | Serology - non-micro


name: Intercellular bridge nuclear Ab pattern | Serum | Serology - non-micro


name: Smooth nuclear envelope nuclear Ab pattern | Body fluid | Serology - non-micro


name: Smooth nuclear envelope nuclear Ab pattern | Cerebral spinal fluid | Serology - non-micro


name: Smooth nuclear envelope nuclear Ab pattern | Serum | Serology - non-micro


name: Spindle fibers nuclear Ab pattern | Cerebral spinal fluid | Serology - non-micro


name: Gastrointestinal dysmotility autoimmune Ab panel | Serum | Serology Panels


name: Myasthenia gravis and Lambert-Eaton syndrome autoimmune Ab panel | Serum | Serology Panels


name: Necrotizing myopathy autoimmune Ab panel | Serum | Serology Panels


name: Nuclear antibody panel | Serum | Serology Panels


name: COVID-19 note | {Setting} | Document ontology


name: COVID-19 note | Telehealth | Document ontology


name: Evaluation note | Emergency department | Document ontology


name: Intravascular mean | Blood central venous | Specific venous blood pressure


name: Blood pressure panel | Arterial system | Blood pressure Panels


name: Blood pressure panel | Patient | Blood pressure Panels


name: Blood pressure with exercise and post exercise panel | Arterial system | Blood pressure Panels


name: Orthostatic blood pressure panel | Arterial system | Blood pressure Panels


name: with canavanine glycine+bromothymol blue


name: Tissue, unspecified.Fine needle aspiration


name: Census tract at cancer Not specified Dx.alternate


name: Anesthetic agent.Not specified+Nitrous oxide


name: DICLOFENAC SODIUM 1 g in 1 g NOT APPLICABLE POWDER


name: DOXAPRAM HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: LACTIDE, DL- 1 g in 1 g NOT APPLICABLE CRYSTAL


name: METHYLPYRROLIDONE 1 kg in 1 kg NOT APPLICABLE LIQUID


name: AVOBENZONE 20 mg in 1 mL / HOMOSALATE 40 mg in 1 mL / OCTISALATE 40 mg in 1 mL / OCTOCRYLENE 20 mg in 1 mL TOPICAL LOTION [Neutrogena Rapid Wrinkle Repair Retinol Moisturizer Sunscreen Broad Spectrum SPF 30 Day]


name: TITANIUM DIOXIDE 78 mg in 1 mL / ZINC OXIDE 250 mg in 1 mL TOPICAL LOTION [Diamond Luminous UV Defense Light Tinted Fluid Sunscreen Broad Spectrum SPF 40]


name: Niacinamide 2.0 g in 100 mL TOPICAL LIQUID [AAPE Skin Ampoule]


name: Niacinamide 0.70 g in 35 mL / Adenosine 0.01 g in 35 mL TOPICAL PATCH [GGULBA MASK]


name: Panthenol 0.5 g in 100 mL TOPICAL LIQUID [AAPE Hair Ampoule]


name: S-ADENOSYL-L-METHIONINE DISULFATE TOSYLATE 1 g in 1 g NOT APPLICABLE POWDER


name: ACCESS,ADAPTER CHAIT COOK #CTU-10.0-18-CAA


name: CATHERIZATION SET,FOLEY 16FR CARDINAL #3716


name: CATHETER FOLEY 2-WAY 18FR 30ML M#DYND11778


name: CATHETER FOLEY 3-WAY 26FR 30ML BARD #0167V26S


name: CATHETER,CLEAN-CATH PVC 18FR BARD#423718


name: CATHETER,FOLEY 2-WAY 26FR 30CC BARD #266726


name: CATHETER,FOLEY 2-WAY SILICONE COUDE 20FR 15ML COLOPLAST#AA6320


name: CATHETER,INTERM,SILICONE 18FR ROCHESTER #63318


name: CATHETER,INTERMITTENT COUDE 14FR CURE #ULTRAM14C


name: CATHETER,SUCTION,14FR KIT CAREFUSION #4664A


name: {4 (brincidofovir 100 MG Oral Tablet [Tembexa]) } Pack [Tembexa 4 Tablet Pack]


name: CATHETER,INTERMITTENT,MAGIC3 12FR BARD #50812G


name: CATHETER,INTERMITTENT,MAGIC3 FEMALE 14FR ROCHESTER #51614


name: CATHETER,SPEEDICATH COMPACT COLOPLAST #28578


name: BANDAGE,ELASTIC,CONFORMING (TRANSELAST) 2.4IN X 4.4YD


name: DRESSING,OPTICELL 6IN X 6IN MEDLINE #MSC7866EP


name: VAD DRIVELINE MAINTENANCE KIT CENTURION #DM280


name: VAD DRIVELINE MAINTENANCE KIT CENTURION #DM395A


name: VAD DRIVELINE MAINTENANCE KIT CENTURION #DM400A


name: ZINC OXIDE 192 mg in 1 mL TOPICAL POWDER [Paulas Choice On-the-Go Shielding Powder Broad Spectrum SPF 30]


name: NITROFURAZONE 1 kg in 1 kg NOT APPLICABLE POWDER


name: ALUMINUM SESQUICHLOROHYDRATE 15 g in 100 mL TOPICAL EMULSION [esika total sec DELICATE SKIN Antiperspirant and deodorant Womens roll-on All day extra effective protection]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL CREAM [Tender Moments Baby Sunscreen Broad Spectrum SPF 50 Water Resistant (40 minutes)]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 37.5 mg in 1 g TOPICAL SPRAY [Premium Moisturizing Sunscreen SPF 30]


name: AVOBENZONE 30 mg in 1 mL / DROMETRIZOLE TRISILOXANE 5 mg in 1 mL / HOMOSALATE 107.2 mg in 1 mL / OCTISALATE 32.1 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL / OXYBENZONE 38.6 mg in 1 mL TOPICAL LOTION [Garnier Ombrelle Sport Endurance 60]


name: AVOBENZONE 50 mg in 1 mL / DROMETRIZOLE TRISILOXANE 10 mg in 1 mL / HOMOSALATE 130 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL SPRAY [Garnier Ombrelle Clear Sport 45 Water Resistant 40 Minutes]


name: AVOBENZONE 50 mg in 1 mL / DROMETRIZOLE TRISILOXANE 20 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL SPRAY [Garnier Ombrelle Clear Sport 50 Plus Water Resistant 40 Minutes]


name: TITANIUM DIOXIDE 90.2 mg in 1 mL / ZINC OXIDE 70 mg in 1 mL TOPICAL LOTION [Garnier Ombrelle Face Mineral 50]


name: LUFENURON 1 kg in 1 kg NOT APPLICABLE POWDER


name: AVOBENZONE 15 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL / ECAMSULE 5 mg in 1 mL / TITANIUM DIOXIDE 25 mg in 1 mL TOPICAL LOTION [Garnier Ombrelle Sport 30 Water Sweat Resistant Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / OXYBENZONE 60 mg in 1 mL TOPICAL SPRAY [Garnier Ombrelle Sport 30]


name: AVOBENZONE 35 mg in 1 mL / DROMETRIZOLE TRISILOXANE 30 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / TITANIUM DIOXIDE 41.5 mg in 1 mL TOPICAL LOTION [Garnier Ombrelle Ultra Light Hydrating Face Sunscreen]


name: Avobenzone 30 mg in 1 g / Homosalate 125 mg in 1 g / Octisalate 50 mg in 1 g / Octocrylene 80 mg in 1 g TOPICAL LOTION [Cetaphil Healthy Radiance Whipped Day Cream Broad Spectrum SPF 30]


name: Sevelamer Carbonate 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / OXYBENZONE 60 mg in 1 mL TOPICAL LOTION [CVS Health Ultra Sheer SPF 100 Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / OXYBENZONE 60 mg in 1 mL TOPICAL LOTION [Harmon Face Values Ultra Light Dry to the Touch SPF 100 Sunscreen]


name: HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL / OCTISALATE 30 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OXYBENZONE 60 mg in 1 mL TOPICAL LOTION [TopCare Everyday Ultimate Sheer Sun Broad Spectrum SPF 70]


name: TITANIUM DIOXIDE 35 mg in 1 g / ZINC OXIDE 72.5 mg in 1 g TOPICAL SPRAY [H.E.B. Mineral Sunscreen Broad Spectrum SPF 50]


name: Titanium Dioxide 40 mg in 1 g / Zinc Oxide 55 mg in 1 g TOPICAL STICK [TiZO Tinted Lip Protection SPF 45]


name: Titanium Dioxide 80 mg in 1 g / Zinc Oxide 38 mg in 1 g TOPICAL CREAM [CoTZ Face Prime and Protect SPF 40 (Non-Tinted)]


name: FLUTICASONE PROPIONATE 1 g in 1 g NOT APPLICABLE POWDER


name: Octocrylene 7 g in 100 mL / Octisalate 5 g in 100 mL / Avobenzone 3 g in 100 mL TOPICAL LOTION [Cetaphil Oil Absorbing SPF 30]


name: ZINC OXIDE 200 mg in 1 g TOPICAL CREAM [TiZO Ultra Zinc SPF 40 (Non-Tinted)]


name: ESTRIOL 5 mg in 85 g TRANSDERMAL CREAM [Estriol 5.0 Cream]


name: ESTRIOL 4 mg in 85 g / ESTRADIOL 1 mg in 85 g TRANSDERMAL CREAM [BiEST 5.0 Estrogen Cream]


name: PROGESTERONE 1 mg in 1 mg TRANSDERMAL CREAM [P50 Progesterone Cream]


name: PROGESTERONE 1 mg in 1 mg TRANSDERMAL CREAM [P75 Lav Progesterone Cream]


name: PROGESTERONE 1 mg in 1 mg TRANSDERMAL CREAM [P75 Maxx with Retinol All Natural Progesterone 75 Cream]


name: PROGESTERONE 25 mg in 85 g TRANSDERMAL CREAM [P25 Progesterone Cream]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [TOPCARE EVERYDAY ULTRA PROTECTION SPF 50]


name: Medical and Surgical @ Central Nervous System and Cranial Nerves @ Extraction @ Brain


name: Medical and Surgical @ Central Nervous System and Cranial Nerves @ Extraction @ Brain @ Open


name: Medical and Surgical @ Central Nervous System and Cranial Nerves @ Extraction @ Brain @ Open @ No Device


name: Medical and Surgical @ Central Nervous System and Cranial Nerves @ Extraction @ Brain @ Percutaneous


name: Medical and Surgical @ Central Nervous System and Cranial Nerves @ Extraction @ Brain @ Percutaneous @ No Device


name: Extraction of Brain, Percutaneous Approach


name: Medical and Surgical @ Central Nervous System and Cranial Nerves @ Extraction @ Brain @ Percutaneous Endoscopic


name: Medical and Surgical @ Central Nervous System and Cranial Nerves @ Extraction @ Brain @ Percutaneous Endoscopic @ No Device


name: Extraction of Brain, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Central Nervous System and Cranial Nerves @ Extraction @ Cerebral Hemisphere


name: Medical and Surgical @ Central Nervous System and Cranial Nerves @ Extraction @ Cerebral Hemisphere @ Open


name: Medical and Surgical @ Central Nervous System and Cranial Nerves @ Extraction @ Cerebral Hemisphere @ Open @ No Device


name: Extraction of Cerebral Hemisphere, Open Approach


name: Medical and Surgical @ Central Nervous System and Cranial Nerves @ Extraction @ Cerebral Hemisphere @ Percutaneous


name: Medical and Surgical @ Central Nervous System and Cranial Nerves @ Extraction @ Cerebral Hemisphere @ Percutaneous @ No Device


name: Extraction of Cerebral Hemisphere, Percutaneous Approach


name: Medical and Surgical @ Central Nervous System and Cranial Nerves @ Extraction @ Cerebral Hemisphere @ Percutaneous Endoscopic


name: Medical and Surgical @ Central Nervous System and Cranial Nerves @ Extraction @ Cerebral Hemisphere @ Percutaneous Endoscopic @ No Device


name: Extraction of Cerebral Hemisphere, Percutaneous Endoscopic Approach


name: Extirpation of Matter from Coronary Artery, One Artery, Orbital Atherectomy Technique, Percutaneous Approach


name: Extirpation of Matter from Coronary Artery, Two Arteries, Orbital Atherectomy Technique, Percutaneous Approach


name: Extirpation of Matter from Coronary Artery, Three Arteries, Orbital Atherectomy Technique, Percutaneous Approach


name: Extirpation of Matter from Coronary Artery, Four or More Arteries, Orbital Atherectomy Technique, Percutaneous Approach


name: Medical and Surgical @ Heart and Great Vessels @ Fragmentation @ Coronary Artery, One Artery


name: Medical and Surgical @ Heart and Great Vessels @ Fragmentation @ Coronary Artery, One Artery @ Percutaneous


name: Medical and Surgical @ Heart and Great Vessels @ Fragmentation @ Coronary Artery, One Artery @ Percutaneous @ No Device


name: Fragmentation in Coronary Artery, One Artery, Percutaneous Approach


name: Medical and Surgical @ Heart and Great Vessels @ Fragmentation @ Coronary Artery, Two Arteries


name: Medical and Surgical @ Heart and Great Vessels @ Fragmentation @ Coronary Artery, Two Arteries @ Percutaneous


name: Medical and Surgical @ Heart and Great Vessels @ Fragmentation @ Coronary Artery, Two Arteries @ Percutaneous @ No Device


name: Fragmentation in Coronary Artery, Two Arteries, Percutaneous Approach


name: Medical and Surgical @ Heart and Great Vessels @ Fragmentation @ Coronary Artery, Three Arteries


name: Medical and Surgical @ Heart and Great Vessels @ Fragmentation @ Coronary Artery, Three Arteries @ Percutaneous


name: Medical and Surgical @ Heart and Great Vessels @ Fragmentation @ Coronary Artery, Three Arteries @ Percutaneous @ No Device


name: Fragmentation in Coronary Artery, Three Arteries, Percutaneous Approach


name: Medical and Surgical @ Heart and Great Vessels @ Fragmentation @ Coronary Artery, Four or More Arteries


name: Medical and Surgical @ Heart and Great Vessels @ Fragmentation @ Coronary Artery, Four or More Arteries @ Percutaneous


name: Medical and Surgical @ Heart and Great Vessels @ Fragmentation @ Coronary Artery, Four or More Arteries @ Percutaneous @ No Device


name: Fragmentation in Coronary Artery, Four or More Arteries, Percutaneous Approach


name: Medical and Surgical @ Heart and Great Vessels @ Replacement @ Heart


name: Medical and Surgical @ Heart and Great Vessels @ Replacement @ Heart @ Open


name: Medical and Surgical @ Heart and Great Vessels @ Replacement @ Heart @ Open @ Biologic with Synthetic Substitute, Autoregulated Electrohydraulic


name: Replacement of Heart with Biologic and Synthetic Substitute, Autoregulated Electrohydraulic, Open Approach


name: Medical and Surgical @ Heart and Great Vessels @ Replacement @ Heart @ Open @ Synthetic Substitute, Pneumatic


name: Replacement of Heart with Synthetic Substitute, Pneumatic, Open Approach


name: Replacement of Pulmonary Valve with Zooplastic Tissue, In Existing Conduit, Percutaneous Approach


name: Replacement of Pulmonary Valve with Zooplastic Tissue, Native Site, Percutaneous Approach


name: Medical and Surgical @ Heart and Great Vessels @ Restriction @ Ventricle, Left


name: Medical and Surgical @ Heart and Great Vessels @ Restriction @ Ventricle, Left @ Open


name: Medical and Surgical @ Heart and Great Vessels @ Restriction @ Ventricle, Left @ Open @ Extraluminal Device


name: Restriction of Left Ventricle with Extraluminal Device, Open Approach


name: Medical and Surgical @ Heart and Great Vessels @ Restriction @ Ventricle, Left @ Open @ Intraluminal Device


name: Restriction of Left Ventricle with Intraluminal Device, Open Approach


name: Medical and Surgical @ Heart and Great Vessels @ Restriction @ Ventricle, Left @ Open @ No Device


name: Restriction of Left Ventricle, Open Approach


name: Medical and Surgical @ Heart and Great Vessels @ Restriction @ Ventricle, Left @ Percutaneous


name: Medical and Surgical @ Heart and Great Vessels @ Restriction @ Ventricle, Left @ Percutaneous @ Extraluminal Device


name: Restriction of Left Ventricle with Extraluminal Device, Percutaneous Approach


name: Medical and Surgical @ Heart and Great Vessels @ Restriction @ Ventricle, Left @ Percutaneous @ Intraluminal Device


name: Restriction of Left Ventricle with Intraluminal Device, Percutaneous Approach


name: Medical and Surgical @ Heart and Great Vessels @ Restriction @ Ventricle, Left @ Percutaneous @ No Device


name: Restriction of Left Ventricle, Percutaneous Approach


name: Medical and Surgical @ Heart and Great Vessels @ Restriction @ Ventricle, Left @ Percutaneous Endoscopic


name: Medical and Surgical @ Heart and Great Vessels @ Restriction @ Ventricle, Left @ Percutaneous Endoscopic @ Extraluminal Device


name: Restriction of Left Ventricle with Extraluminal Device, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Heart and Great Vessels @ Restriction @ Ventricle, Left @ Percutaneous Endoscopic @ Intraluminal Device


name: Restriction of Left Ventricle with Intraluminal Device, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Heart and Great Vessels @ Restriction @ Ventricle, Left @ Percutaneous Endoscopic @ No Device


name: Restriction of Left Ventricle, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Upper Arteries @ Bypass @ Brachial Artery, Right @ Percutaneous


name: Medical and Surgical @ Upper Arteries @ Bypass @ Brachial Artery, Right @ Percutaneous @ No Device


name: Bypass Right Brachial Artery to Lower Arm Vein, Percutaneous Approach


name: Medical and Surgical @ Upper Arteries @ Bypass @ Brachial Artery, Left @ Percutaneous


name: Medical and Surgical @ Upper Arteries @ Bypass @ Brachial Artery, Left @ Percutaneous @ No Device


name: Bypass Left Brachial Artery to Lower Arm Vein, Percutaneous Approach


name: Medical and Surgical @ Upper Arteries @ Fragmentation @ Intracranial Artery


name: Medical and Surgical @ Upper Arteries @ Fragmentation @ Intracranial Artery @ Percutaneous


name: Medical and Surgical @ Upper Arteries @ Fragmentation @ Intracranial Artery @ Percutaneous @ No Device


name: Fragmentation of Intracranial Artery, Percutaneous Approach, Ultrasonic


name: Fragmentation of Intracranial Artery, Percutaneous Approach


name: Medical and Surgical @ Lower Veins @ Occlusion @ Lower Vein @ Via Natural or Artificial Opening


name: Medical and Surgical @ Lower Veins @ Occlusion @ Lower Vein @ Via Natural or Artificial Opening @ Extraluminal Device


name: Occlusion of Hemorrhoidal Plexus with Extraluminal Device, Via Natural or Artificial Opening


name: Occlusion of Lower Vein with Extraluminal Device, Via Natural or Artificial Opening


name: Medical and Surgical @ Lower Veins @ Occlusion @ Lower Vein @ Via Natural or Artificial Opening @ Intraluminal Device


name: Occlusion of Hemorrhoidal Plexus with Intraluminal Device, Via Natural or Artificial Opening


name: Occlusion of Lower Vein with Intraluminal Device, Via Natural or Artificial Opening


name: Medical and Surgical @ Lower Veins @ Occlusion @ Lower Vein @ Via Natural or Artificial Opening @ No Device


name: Occlusion of Hemorrhoidal Plexus, Via Natural or Artificial Opening


name: Occlusion of Lower Vein, Via Natural or Artificial Opening


name: Medical and Surgical @ Lower Veins @ Occlusion @ Lower Vein @ Via Natural or Artificial Opening Endoscopic


name: Medical and Surgical @ Lower Veins @ Occlusion @ Lower Vein @ Via Natural or Artificial Opening Endoscopic @ Extraluminal Device


name: Occlusion of Hemorrhoidal Plexus with Extraluminal Device, Via Natural or Artificial Opening Endoscopic


name: Occlusion of Lower Vein with Extraluminal Device, Via Natural or Artificial Opening Endoscopic


name: Medical and Surgical @ Lower Veins @ Occlusion @ Lower Vein @ Via Natural or Artificial Opening Endoscopic @ Intraluminal Device


name: Occlusion of Hemorrhoidal Plexus with Intraluminal Device, Via Natural or Artificial Opening Endoscopic


name: Occlusion of Lower Vein with Intraluminal Device, Via Natural or Artificial Opening Endoscopic


name: Medical and Surgical @ Lower Veins @ Occlusion @ Lower Vein @ Via Natural or Artificial Opening Endoscopic @ No Device


name: Occlusion of Hemorrhoidal Plexus, Via Natural or Artificial Opening Endoscopic


name: Occlusion of Lower Vein, Via Natural or Artificial Opening Endoscopic


name: Medical and Surgical @ Lymphatic and Hemic Systems @ Extraction @ Bone Marrow


name: Medical and Surgical @ Lymphatic and Hemic Systems @ Extraction @ Bone Marrow @ Open


name: Medical and Surgical @ Lymphatic and Hemic Systems @ Extraction @ Bone Marrow @ Open @ No Device


name: Extraction of Bone Marrow, Open Approach, Diagnostic


name: Extraction of Bone Marrow, Open Approach


name: Medical and Surgical @ Lymphatic and Hemic Systems @ Extraction @ Bone Marrow @ Percutaneous


name: Medical and Surgical @ Lymphatic and Hemic Systems @ Extraction @ Bone Marrow @ Percutaneous @ No Device


name: Extraction of Bone Marrow, Percutaneous Approach, Diagnostic


name: Extraction of Bone Marrow, Percutaneous Approach


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver @ Open


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver @ Open @ No Device


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver @ Percutaneous


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver @ Percutaneous @ No Device


name: Division of Liver, Percutaneous Approach


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver @ Percutaneous Endoscopic


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver @ Percutaneous Endoscopic @ No Device


name: Division of Liver, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver, Right Lobe


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver, Right Lobe @ Open


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver, Right Lobe @ Open @ No Device


name: Division of Right Lobe Liver, Open Approach


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver, Right Lobe @ Percutaneous


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver, Right Lobe @ Percutaneous @ No Device


name: Division of Right Lobe Liver, Percutaneous Approach


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver, Right Lobe @ Percutaneous Endoscopic


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver, Right Lobe @ Percutaneous Endoscopic @ No Device


name: Division of Right Lobe Liver, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver, Left Lobe


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver, Left Lobe @ Open


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver, Left Lobe @ Open @ No Device


name: Division of Left Lobe Liver, Open Approach


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver, Left Lobe @ Percutaneous


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver, Left Lobe @ Percutaneous @ No Device


name: Division of Left Lobe Liver, Percutaneous Approach


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver, Left Lobe @ Percutaneous Endoscopic


name: Medical and Surgical @ Hepatobiliary System and Pancreas @ Division @ Liver, Left Lobe @ Percutaneous Endoscopic @ No Device


name: Division of Left Lobe Liver, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Muscles @ Division @ Tongue, Palate, Pharynx Muscle @ Via Natural or Artificial Opening


name: Medical and Surgical @ Muscles @ Division @ Tongue, Palate, Pharynx Muscle @ Via Natural or Artificial Opening @ No Device


name: Division of Tongue, Palate, Pharynx Muscle, Via Natural or Artificial Opening


name: Medical and Surgical @ Muscles @ Division @ Tongue, Palate, Pharynx Muscle @ Via Natural or Artificial Opening Endoscopic


name: Medical and Surgical @ Muscles @ Division @ Tongue, Palate, Pharynx Muscle @ Via Natural or Artificial Opening Endoscopic @ No Device


name: Division of Tongue, Palate, Pharynx Muscle, Via Natural or Artificial Opening Endoscopic


name: Medical and Surgical @ Head and Facial Bones @ Insertion @ Skull @ Open @ Infusion Device


name: Insertion of Infusion Device into Skull, Open Approach


name: Medical and Surgical @ Head and Facial Bones @ Insertion @ Skull @ Percutaneous @ Infusion Device


name: Insertion of Infusion Device into Skull, Percutaneous Approach


name: Medical and Surgical @ Head and Facial Bones @ Insertion @ Skull @ Percutaneous Endoscopic @ Infusion Device


name: Insertion of Infusion Device into Skull, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Upper Bones @ Reposition @ Thoracic Vertebra @ Open @ Spinal Stabilization Device, Vertebral Body Tether


name: Reposition Thoracic Vertebra with Spinal Stabilization Device, Vertebral Body Tether, Open Approach


name: Medical and Surgical @ Upper Bones @ Reposition @ Thoracic Vertebra @ Percutaneous Endoscopic @ Spinal Stabilization Device, Vertebral Body Tether


name: Reposition Thoracic Vertebra with Spinal Stabilization Device, Vertebral Body Tether, Percutaneous Endoscopic Approach


name: Excision of Right Metatarsal, Sesamoid Bone(s) 1st Toe, Open Approach


name: Excision of Right Metatarsal, Sesamoid Bone(s) 1st Toe, Percutaneous Approach


name: Excision of Right Metatarsal, Sesamoid Bone(s) 1st Toe, Percutaneous Endoscopic Approach


name: Excision of Left Metatarsal, Sesamoid Bone(s) 1st Toe, Open Approach


name: Excision of Left Metatarsal, Sesamoid Bone(s) 1st Toe, Percutaneous Approach


name: Excision of Left Metatarsal, Sesamoid Bone(s) 1st Toe, Percutaneous Endoscopic Approach


name: Medical and Surgical @ Lower Bones @ Reposition @ Lumbar Vertebra @ Open @ Spinal Stabilization Device, Vertebral Body Tether


name: Reposition Lumbar Vertebra with Spinal Stabilization Device, Vertebral Body Tether, Open Approach


name: Medical and Surgical @ Lower Bones @ Reposition @ Lumbar Vertebra @ Percutaneous Endoscopic @ Spinal Stabilization Device, Vertebral Body Tether


name: Reposition Lumbar Vertebra with Spinal Stabilization Device, Vertebral Body Tether, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Right Shoulder Joint, Humeral Surface, Open Approach


name: Removal of Synthetic Substitute from Right Shoulder Joint, Glenoid Surface, Open Approach


name: Removal of Synthetic Substitute from Right Shoulder Joint, Humeral Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Right Shoulder Joint, Glenoid Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Right Shoulder Joint, Humeral Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Right Shoulder Joint, Glenoid Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Left Shoulder Joint, Humeral Surface, Open Approach


name: Removal of Synthetic Substitute from Left Shoulder Joint, Glenoid Surface, Open Approach


name: Removal of Synthetic Substitute from Left Shoulder Joint, Humeral Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Left Shoulder Joint, Glenoid Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Left Shoulder Joint, Humeral Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Left Shoulder Joint, Glenoid Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Right Shoulder Joint, Humeral Surface, Open Approach


name: Revision of Synthetic Substitute in Right Shoulder Joint, Glenoid Surface, Open Approach


name: Revision of Synthetic Substitute in Right Shoulder Joint, Humeral Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Right Shoulder Joint, Glenoid Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Right Shoulder Joint, Humeral Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Right Shoulder Joint, Glenoid Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Right Shoulder Joint, Humeral Surface, External Approach


name: Revision of Synthetic Substitute in Right Shoulder Joint, Glenoid Surface, External Approach


name: Revision of Synthetic Substitute in Left Shoulder Joint, Humeral Surface, Open Approach


name: Revision of Synthetic Substitute in Left Shoulder Joint, Glenoid Surface, Open Approach


name: Revision of Synthetic Substitute in Left Shoulder Joint, Humeral Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Left Shoulder Joint, Glenoid Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Left Shoulder Joint, Humeral Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Left Shoulder Joint, Glenoid Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Left Shoulder Joint, Humeral Surface, External Approach


name: Revision of Synthetic Substitute in Left Shoulder Joint, Glenoid Surface, External Approach


name: Administration @ Circulatory @ Transfusion @ Peripheral Vein @ Percutaneous @ Pathogen Reduced Cryoprecipitated Fibrinogen Complex


name: Transfusion of Nonautologous Pathogen Reduced Cryoprecipitated Fibrinogen Complex into Peripheral Vein, Percutaneous Approach


name: Administration @ Circulatory @ Transfusion @ Central Vein @ Percutaneous @ Pathogen Reduced Cryoprecipitated Fibrinogen Complex


name: Transfusion of Nonautologous Pathogen Reduced Cryoprecipitated Fibrinogen Complex into Central Vein, Percutaneous Approach


name: Administration @ Physiological Systems and Anatomical Regions @ Irrigation @ Peritoneal Cavity @ Percutaneous Endoscopic


name: Administration @ Physiological Systems and Anatomical Regions @ Irrigation @ Peritoneal Cavity @ Percutaneous Endoscopic @ Irrigating Substance


name: Irrigation of Peritoneal Cavity using Irrigating Substance, Percutaneous Endoscopic Approach, Diagnostic


name: Irrigation of Peritoneal Cavity using Irrigating Substance, Percutaneous Endoscopic Approach


name: Measurement and Monitoring @ Physiological Devices @ Measurement @ Central Nervous @ External @ Cerebrospinal Fluid Shunt


name: Measurement of Central Nervous Cerebrospinal Fluid Shunt using Wireless Sensor, External Approach


name: Performance of Cardiac Output, Continuous, Automated


name: Imaging @ Hepatobiliary System and Pancreas @ Fluoroscopy @ Liver


name: Imaging @ Hepatobiliary System and Pancreas @ Fluoroscopy @ Liver @ High Osmolar


name: Imaging @ Hepatobiliary System and Pancreas @ Fluoroscopy @ Liver @ High Osmolar @ None


name: Fluoroscopy of Liver using High Osmolar Contrast


name: Imaging @ Hepatobiliary System and Pancreas @ Fluoroscopy @ Liver @ Low Osmolar


name: Imaging @ Hepatobiliary System and Pancreas @ Fluoroscopy @ Liver @ Low Osmolar @ None


name: Fluoroscopy of Liver using Low Osmolar Contrast


name: Imaging @ Hepatobiliary System and Pancreas @ Fluoroscopy @ Liver @ Other Contrast


name: Imaging @ Hepatobiliary System and Pancreas @ Fluoroscopy @ Liver @ Other Contrast @ None


name: Fluoroscopy of Liver using Other Contrast


name: Imaging @ Hepatobiliary System and Pancreas @ Fluoroscopy @ Liver @ None


name: Imaging @ Hepatobiliary System and Pancreas @ Fluoroscopy @ Liver @ None @ None


name: New Technology @ Cardiovascular System @ Extirpation @ Abdominal Aorta


name: New Technology @ Cardiovascular System @ Extirpation @ Abdominal Aorta @ Percutaneous


name: New Technology @ Cardiovascular System @ Extirpation @ Abdominal Aorta @ Percutaneous @ Computer-aided Mechanical Aspiration


name: Extirpation of Matter from Abdominal Aorta using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7


name: New Technology @ Cardiovascular System @ Extirpation @ Upper Extremity Vein, Right


name: New Technology @ Cardiovascular System @ Extirpation @ Upper Extremity Vein, Right @ Percutaneous


name: New Technology @ Cardiovascular System @ Extirpation @ Upper Extremity Vein, Right @ Percutaneous @ Computer-aided Mechanical Aspiration


name: Extirpation of Matter from Right Upper Extremity Vein using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7


name: New Technology @ Cardiovascular System @ Extirpation @ Upper Extremity Vein, Left


name: New Technology @ Cardiovascular System @ Extirpation @ Upper Extremity Vein, Left @ Percutaneous


name: New Technology @ Cardiovascular System @ Extirpation @ Upper Extremity Vein, Left @ Percutaneous @ Computer-aided Mechanical Aspiration


name: Extirpation of Matter from Left Upper Extremity Vein using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7


name: New Technology @ Cardiovascular System @ Extirpation @ Lower Extremity Artery, Right


name: New Technology @ Cardiovascular System @ Extirpation @ Lower Extremity Artery, Right @ Percutaneous


name: New Technology @ Cardiovascular System @ Extirpation @ Lower Extremity Artery, Right @ Percutaneous @ Computer-aided Mechanical Aspiration


name: Extirpation of Matter from Right Lower Extremity Artery using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7


name: New Technology @ Cardiovascular System @ Extirpation @ Lower Extremity Artery, Left


name: New Technology @ Cardiovascular System @ Extirpation @ Lower Extremity Artery, Left @ Percutaneous


name: New Technology @ Cardiovascular System @ Extirpation @ Lower Extremity Artery, Left @ Percutaneous @ Computer-aided Mechanical Aspiration


name: Extirpation of Matter from Left Lower Extremity Artery using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7


name: New Technology @ Cardiovascular System @ Extirpation @ Lower Extremity Vein, Right


name: New Technology @ Cardiovascular System @ Extirpation @ Lower Extremity Vein, Right @ Percutaneous


name: New Technology @ Cardiovascular System @ Extirpation @ Lower Extremity Vein, Right @ Percutaneous @ Computer-aided Mechanical Aspiration


name: Extirpation of Matter from Right Lower Extremity Vein using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7


name: New Technology @ Cardiovascular System @ Extirpation @ Lower Extremity Vein, Left


name: New Technology @ Cardiovascular System @ Extirpation @ Lower Extremity Vein, Left @ Percutaneous


name: New Technology @ Cardiovascular System @ Extirpation @ Lower Extremity Vein, Left @ Percutaneous @ Computer-aided Mechanical Aspiration


name: Extirpation of Matter from Left Lower Extremity Vein using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7


name: New Technology @ Cardiovascular System @ Extirpation @ Great Vessel


name: New Technology @ Cardiovascular System @ Extirpation @ Great Vessel @ Percutaneous


name: New Technology @ Cardiovascular System @ Extirpation @ Great Vessel @ Percutaneous @ Computer-aided Mechanical Aspiration


name: Extirpation of Matter from Great Vessel using Computer-aided Mechanical Aspiration, Percutaneous Approach, New Technology Group 7


name: New Technology @ Cardiovascular System @ Inspection


name: New Technology @ Cardiovascular System @ Inspection @ Heart


name: New Technology @ Cardiovascular System @ Inspection @ Heart @ External


name: New Technology @ Cardiovascular System @ Inspection @ Heart @ External @ Transthoracic Echocardiography, Computer-aided Guidance


name: Inspection of Heart using Transthoracic Echocardiography, Computer-aided Guidance, New Technology Group 7


name: New Technology @ Cardiovascular System @ Bypass


name: New Technology @ Cardiovascular System @ Bypass @ Radial Artery, Right


name: New Technology @ Cardiovascular System @ Bypass @ Radial Artery, Right @ Percutaneous


name: New Technology @ Cardiovascular System @ Bypass @ Radial Artery, Right @ Percutaneous @ Thermal Resistance Energy


name: Bypass Right Radial Artery using Thermal Resistance Energy, Percutaneous Approach, New Technology Group 7


name: New Technology @ Cardiovascular System @ Bypass @ Radial Artery, Left


name: New Technology @ Cardiovascular System @ Bypass @ Radial Artery, Left @ Percutaneous


name: New Technology @ Cardiovascular System @ Bypass @ Radial Artery, Left @ Percutaneous @ Thermal Resistance Energy


name: Bypass Left Radial Artery using Thermal Resistance Energy, Percutaneous Approach, New Technology Group 7


name: New Technology @ Cardiovascular System @ Replacement @ Thoracic Aorta, Arch


name: New Technology @ Cardiovascular System @ Replacement @ Thoracic Aorta, Arch @ Open


name: New Technology @ Cardiovascular System @ Replacement @ Thoracic Aorta, Arch @ Open @ Branched Synthetic Substitute with Intraluminal Device


name: Replacement of Thoracic Aorta, Arch using Branched Synthetic Substitute with Intraluminal Device, Open Approach, New Technology Group 7


name: New Technology @ Cardiovascular System @ Restriction


name: New Technology @ Cardiovascular System @ Restriction @ Coronary Sinus


name: New Technology @ Cardiovascular System @ Restriction @ Coronary Sinus @ Percutaneous


name: New Technology @ Cardiovascular System @ Restriction @ Coronary Sinus @ Percutaneous @ Reduction Device


name: Restriction of Coronary Sinus with Reduction Device, Percutaneous Approach, New Technology Group 7


name: New Technology @ Cardiovascular System @ Restriction @ Thoracic Aorta, Descending


name: New Technology @ Cardiovascular System @ Restriction @ Thoracic Aorta, Descending @ Open


name: New Technology @ Cardiovascular System @ Restriction @ Thoracic Aorta, Descending @ Open @ Branched Synthetic Substitute with Intraluminal Device


name: Restriction of Thoracic Aorta, Descending using Branched Synthetic Substitute with Intraluminal Device, Open Approach, New Technology Group 7


name: New Technology @ Gastrointestinal System (Procedure)


name: New Technology @ Gastrointestinal System @ Monitoring


name: New Technology @ Gastrointestinal System @ Monitoring @ Upper GI


name: New Technology @ Gastrointestinal System @ Monitoring @ Upper GI @ Percutaneous Endoscopic


name: New Technology @ Gastrointestinal System @ Monitoring @ Upper GI @ Percutaneous Endoscopic @ Oxygen Saturation


name: Monitoring of Upper GI Oxygen Saturation, Percutaneous Endoscopic Approach, New Technology Group 7


name: New Technology @ Gastrointestinal System @ Monitoring @ Upper GI @ Via Natural or Artificial Opening Endoscopic


name: New Technology @ Gastrointestinal System @ Monitoring @ Upper GI @ Via Natural or Artificial Opening Endoscopic @ Oxygen Saturation


name: Monitoring of Upper GI Oxygen Saturation, Via Natural or Artificial Opening Endoscopic, New Technology Group 7


name: New Technology @ Gastrointestinal System @ Monitoring @ Lower GI


name: New Technology @ Gastrointestinal System @ Monitoring @ Lower GI @ Percutaneous Endoscopic


name: New Technology @ Gastrointestinal System @ Monitoring @ Lower GI @ Percutaneous Endoscopic @ Oxygen Saturation


name: Monitoring of Lower GI Oxygen Saturation, Percutaneous Endoscopic Approach, New Technology Group 7


name: New Technology @ Gastrointestinal System @ Monitoring @ Lower GI @ Via Natural or Artificial Opening Endoscopic


name: New Technology @ Gastrointestinal System @ Monitoring @ Lower GI @ Via Natural or Artificial Opening Endoscopic @ Oxygen Saturation


name: Monitoring of Lower GI Oxygen Saturation, Via Natural or Artificial Opening Endoscopic, New Technology Group 7


name: New Technology @ Gastrointestinal System @ Irrigation


name: New Technology @ Gastrointestinal System @ Irrigation @ Lower GI


name: New Technology @ Gastrointestinal System @ Irrigation @ Lower GI @ Via Natural or Artificial Opening Endoscopic


name: New Technology @ Gastrointestinal System @ Irrigation @ Lower GI @ Via Natural or Artificial Opening Endoscopic @ Intraoperative Single-use Oversleeve


name: Irrigation of Lower GI using Intraoperative Single-use Oversleeve, Via Natural or Artificial Opening Endoscopic, New Technology Group 7


name: New Technology @ Hepatobiliary System and Pancreas (Procedure)


name: New Technology @ Hepatobiliary System and Pancreas @ Inspection


name: New Technology @ Hepatobiliary System and Pancreas @ Inspection @ Hepatobiliary Duct


name: New Technology @ Hepatobiliary System and Pancreas @ Inspection @ Hepatobiliary Duct @ Via Natural or Artificial Opening Endoscopic


name: New Technology @ Hepatobiliary System and Pancreas @ Inspection @ Hepatobiliary Duct @ Via Natural or Artificial Opening Endoscopic @ Single-use Duodenoscope


name: Inspection of Hepatobiliary Duct using Single-use Duodenoscope, New Technology Group 7


name: New Technology @ Hepatobiliary System and Pancreas @ Inspection @ Pancreatic Duct


name: New Technology @ Hepatobiliary System and Pancreas @ Inspection @ Pancreatic Duct @ Via Natural or Artificial Opening Endoscopic


name: New Technology @ Hepatobiliary System and Pancreas @ Inspection @ Pancreatic Duct @ Via Natural or Artificial Opening Endoscopic @ Single-use Duodenoscope


name: Inspection of Pancreatic Duct using Single-use Duodenoscope, New Technology Group 7


name: New Technology @ Skin, Subcutaneous Tissue, Fascia and Breast @ Replacement @ Skin @ External @ Bioengineered Allogeneic Construct


name: Replacement of Skin with Bioengineered Allogeneic Construct, External Approach, New Technology Group 7


name: New Technology @ Bones @ Reposition @ Lumbar Vertebra @ Open @ Posterior (Dynamic) Distraction Device


name: Reposition of Lumbar Vertebra using Posterior (Dynamic) Distraction Device, Open Approach, New Technology Group 7


name: New Technology @ Bones @ Reposition @ Lumbar Vertebra @ Percutaneous @ Posterior (Dynamic) Distraction Device


name: Reposition of Lumbar Vertebra using Posterior (Dynamic) Distraction Device, Percutaneous Approach, New Technology Group 7


name: New Technology @ Bones @ Reposition @ Thoracic Vertebra @ Open @ Posterior (Dynamic) Distraction Device


name: Reposition of Thoracic Vertebra using Posterior (Dynamic) Distraction Device, Open Approach, New Technology Group 7


name: New Technology @ Bones @ Reposition @ Thoracic Vertebra @ Percutaneous @ Posterior (Dynamic) Distraction Device


name: Reposition of Thoracic Vertebra using Posterior (Dynamic) Distraction Device, Percutaneous Approach, New Technology Group 7


name: New Technology @ Joints @ Fusion @ Thoracolumbar Vertebral Joint @ Open @ Interbody Fusion Device, Custom-Made Anatomically Designed


name: Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7


name: New Technology @ Joints @ Fusion @ Thoracolumbar Vertebral Joint @ Percutaneous


name: New Technology @ Joints @ Fusion @ Thoracolumbar Vertebral Joint @ Percutaneous @ Interbody Fusion Device, Custom-Made Anatomically Designed


name: Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7


name: New Technology @ Joints @ Fusion @ Thoracolumbar Vertebral Joint @ Percutaneous Endoscopic


name: New Technology @ Joints @ Fusion @ Thoracolumbar Vertebral Joint @ Percutaneous Endoscopic @ Interbody Fusion Device, Custom-Made Anatomically Designed


name: Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7


name: New Technology @ Joints @ Fusion @ Lumbar Vertebral Joint @ Open @ Interbody Fusion Device, Custom-Made Anatomically Designed


name: Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7


name: New Technology @ Joints @ Fusion @ Lumbar Vertebral Joint @ Percutaneous


name: New Technology @ Joints @ Fusion @ Lumbar Vertebral Joint @ Percutaneous @ Interbody Fusion Device, Custom-Made Anatomically Designed


name: Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7


name: New Technology @ Joints @ Fusion @ Lumbar Vertebral Joint @ Percutaneous Endoscopic


name: New Technology @ Joints @ Fusion @ Lumbar Vertebral Joint @ Percutaneous Endoscopic @ Interbody Fusion Device, Custom-Made Anatomically Designed


name: Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7


name: New Technology @ Joints @ Fusion @ Lumbar Vertebral Joints, 2 or more @ Open @ Interbody Fusion Device, Custom-Made Anatomically Designed


name: Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7


name: New Technology @ Joints @ Fusion @ Lumbar Vertebral Joints, 2 or more @ Percutaneous


name: New Technology @ Joints @ Fusion @ Lumbar Vertebral Joints, 2 or more @ Percutaneous @ Interbody Fusion Device, Custom-Made Anatomically Designed


name: Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7


name: New Technology @ Joints @ Fusion @ Lumbar Vertebral Joints, 2 or more @ Percutaneous Endoscopic


name: New Technology @ Joints @ Fusion @ Lumbar Vertebral Joints, 2 or more @ Percutaneous Endoscopic @ Interbody Fusion Device, Custom-Made Anatomically Designed


name: Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7


name: New Technology @ Joints @ Fusion @ Lumbosacral Joint @ Open @ Interbody Fusion Device, Custom-Made Anatomically Designed


name: Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7


name: New Technology @ Joints @ Fusion @ Lumbosacral Joint @ Percutaneous


name: New Technology @ Joints @ Fusion @ Lumbosacral Joint @ Percutaneous @ Interbody Fusion Device, Custom-Made Anatomically Designed


name: Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7


name: New Technology @ Joints @ Fusion @ Lumbosacral Joint @ Percutaneous Endoscopic


name: New Technology @ Joints @ Fusion @ Lumbosacral Joint @ Percutaneous Endoscopic @ Interbody Fusion Device, Custom-Made Anatomically Designed


name: Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Introduction @ Skin


name: New Technology @ Anatomical Regions @ Introduction @ Skin @ External


name: New Technology @ Anatomical Regions @ Introduction @ Skin @ External @ Anacaulase-bcdb


name: Introduction of Anacaulase-bcdb into Skin, External Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Introduction @ Subcutaneous Tissue @ Percutaneous @ Satralizumab-mwge


name: Introduction of Satralizumab-mwge into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Introduction @ Subcutaneous Tissue @ Percutaneous @ Other New Technology Therapeutic Substance


name: Introduction of Other New Technology Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 5


name: New Technology @ Anatomical Regions @ Introduction @ Subcutaneous Tissue @ Percutaneous @ Other New Technology Monoclonal Antibody


name: Introduction of Other New Technology Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6


name: New Technology @ Anatomical Regions @ Introduction @ Subcutaneous Tissue @ Percutaneous @ Leronlimab Monoclonal Antibody


name: Introduction of Leronlimab Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6


name: New Technology @ Anatomical Regions @ Introduction @ Subcutaneous Tissue @ Percutaneous @ COVID-19 Vaccine Dose 1


name: Introduction of COVID-19 Vaccine Dose 1 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6


name: New Technology @ Anatomical Regions @ Introduction @ Subcutaneous Tissue @ Percutaneous @ COVID-19 Vaccine Dose 2


name: Introduction of COVID-19 Vaccine Dose 2 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6


name: New Technology @ Anatomical Regions @ Introduction @ Subcutaneous Tissue @ Percutaneous @ COVID-19 Vaccine


name: Introduction of COVID-19 Vaccine into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6


name: New Technology @ Anatomical Regions @ Introduction @ Subcutaneous Tissue @ External


name: New Technology @ Anatomical Regions @ Introduction @ Subcutaneous Tissue @ External @ Anacaulase-bcdb


name: Introduction of Anacaulase-bcdb into Subcutaneous Tissue, External Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Introduction @ Muscle


name: New Technology @ Anatomical Regions @ Introduction @ Muscle @ Percutaneous


name: New Technology @ Anatomical Regions @ Introduction @ Muscle @ Percutaneous @ COVID-19 Vaccine Dose 1


name: Introduction of COVID-19 Vaccine Dose 1 into Muscle, Percutaneous Approach, New Technology Group 6


name: New Technology @ Anatomical Regions @ Introduction @ Muscle @ Percutaneous @ COVID-19 Vaccine Dose 2


name: Introduction of COVID-19 Vaccine Dose 2 into Muscle, Percutaneous Approach, New Technology Group 6


name: New Technology @ Anatomical Regions @ Introduction @ Muscle @ Percutaneous @ COVID-19 Vaccine


name: Introduction of COVID-19 Vaccine into Muscle, Percutaneous Approach, New Technology Group 6


name: Introduction of Narsoplimab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Terlipressin into Peripheral Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Trilaciclib into Peripheral Vein, Percutaneous Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Introduction @ Peripheral Vein @ Percutaneous @ Lurbinectedin


name: Introduction of Lurbinectedin into Peripheral Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Ciltacabtagene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Amivantamab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Autologous Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Introduction @ Peripheral Vein @ Percutaneous @ Remdesivir Anti-infective


name: Introduction of Remdesivir Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5


name: Introduction of Other New Technology Therapeutic Substance into Peripheral Vein, Percutaneous Approach, New Technology Group 5


name: Introduction of Sarilumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5


name: Introduction of REGN-COV2 Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 6


name: Introduction of Allogeneic Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Tocilizumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5


name: Introduction of Other New Technology Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 6


name: Introduction of Axicabtagene Ciloleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Introduction @ Peripheral Vein @ Percutaneous @ Tisagenlecleucel Immunotherapy


name: Introduction of Tisagenlecleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Idecabtagene Vicleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Introduction @ Peripheral Vein @ Percutaneous @ CD24Fc Immunomodulator


name: Introduction of CD24Fc Immunomodulator into Peripheral Vein, Percutaneous Approach, New Technology Group 6


name: Introduction of Lifileucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Introduction @ Peripheral Vein @ Percutaneous @ Brexucabtagene Autoleucel Immunotherapy


name: Introduction of Brexucabtagene Autoleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Lisocabtagene Maraleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Narsoplimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Terlipressin into Central Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Trilaciclib into Central Vein, Percutaneous Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Introduction @ Central Vein @ Percutaneous @ Lurbinectedin


name: Introduction of Lurbinectedin into Central Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Ciltacabtagene Autoleucel into Central Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Amivantamab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Autologous Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Introduction @ Central Vein @ Percutaneous @ Remdesivir Anti-infective


name: Introduction of Remdesivir Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5


name: Introduction of Other New Technology Therapeutic Substance into Central Vein, Percutaneous Approach, New Technology Group 5


name: Introduction of Sarilumab into Central Vein, Percutaneous Approach, New Technology Group 5


name: Introduction of REGN-COV2 Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 6


name: Introduction of Allogeneic Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Tocilizumab into Central Vein, Percutaneous Approach, New Technology Group 5


name: Introduction of Other New Technology Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 6


name: Introduction of Axicabtagene Ciloleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Introduction @ Central Vein @ Percutaneous @ Tisagenlecleucel Immunotherapy


name: Introduction of Tisagenlecleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Idecabtagene Vicleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Introduction @ Central Vein @ Percutaneous @ CD24Fc Immunomodulator


name: Introduction of CD24Fc Immunomodulator into Central Vein, Percutaneous Approach, New Technology Group 6


name: Introduction of Lifileucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Introduction @ Central Vein @ Percutaneous @ Brexucabtagene Autoleucel Immunotherapy


name: Introduction of Brexucabtagene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7


name: Introduction of Lisocabtagene Maraleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Introduction @ Mouth and Pharynx @ External @ Other New Technology Therapeutic Substance


name: Introduction of Other New Technology Therapeutic Substance into Mouth and Pharynx, External Approach, New Technology Group 5


name: New Technology @ Anatomical Regions @ Introduction @ Mouth and Pharynx @ External @ Baricitinib


name: Introduction of Baricitinib into Mouth and Pharynx, External Approach, New Technology Group 6


name: New Technology @ Anatomical Regions @ Introduction @ Upper GI @ Via Natural or Artificial Opening


name: New Technology @ Anatomical Regions @ Introduction @ Upper GI @ Via Natural or Artificial Opening @ Baricitinib


name: Introduction of Baricitinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 6


name: New Technology @ Anatomical Regions @ Introduction @ Lower GI @ Via Natural or Artificial Opening


name: New Technology @ Anatomical Regions @ Introduction @ Lower GI @ Via Natural or Artificial Opening @ Baricitinib


name: Introduction of Baricitinib into Lower GI, Via Natural or Artificial Opening, New Technology Group 6


name: New Technology @ Anatomical Regions @ Introduction @ Bones


name: New Technology @ Anatomical Regions @ Introduction @ Bones @ Open


name: New Technology @ Anatomical Regions @ Introduction @ Bones @ Open @ Antibiotic-eluting Bone Void Filler


name: Introduction of Antibiotic-eluting Bone Void Filler into Bones, Open Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Transfusion


name: New Technology @ Anatomical Regions @ Transfusion @ Peripheral Vein


name: New Technology @ Anatomical Regions @ Transfusion @ Peripheral Vein @ Percutaneous


name: New Technology @ Anatomical Regions @ Transfusion @ Peripheral Vein @ Percutaneous @ Plasma, Convalescent (Nonautologous)


name: Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5


name: New Technology @ Anatomical Regions @ Transfusion @ Peripheral Vein @ Percutaneous @ High-Dose Intravenous Immune Globulin


name: Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Transfusion @ Peripheral Vein @ Percutaneous @ Hyperimmune Globulin


name: Transfusion of Hyperimmune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Transfusion @ Central Vein


name: New Technology @ Anatomical Regions @ Transfusion @ Central Vein @ Percutaneous


name: New Technology @ Anatomical Regions @ Transfusion @ Central Vein @ Percutaneous @ Plasma, Convalescent (Nonautologous)


name: Transfusion of Convalescent Plasma (Nonautologous) into Central Vein, Percutaneous Approach, New Technology Group 5


name: New Technology @ Anatomical Regions @ Transfusion @ Central Vein @ Percutaneous @ High-Dose Intravenous Immune Globulin


name: Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Transfusion @ Central Vein @ Percutaneous @ Hyperimmune Globulin


name: Transfusion of Hyperimmune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7


name: New Technology @ Anatomical Regions @ Insertion


name: New Technology @ Anatomical Regions @ Insertion @ Mouth and Pharynx


name: New Technology @ Anatomical Regions @ Insertion @ Mouth and Pharynx @ Via Natural or Artificial Opening


name: New Technology @ Anatomical Regions @ Insertion @ Mouth and Pharynx @ Via Natural or Artificial Opening @ Neurostimulator Lead


name: Insertion of Neurostimulator Lead into Mouth and Pharynx, Via Natural or Artificial Opening, New Technology Group 7


name: New Technology @ Physiological Systems @ Measurement @ Central Nervous


name: New Technology @ Physiological Systems @ Measurement @ Central Nervous @ External


name: New Technology @ Physiological Systems @ Measurement @ Central Nervous @ External @ Intracranial Vascular Activity, Computer-aided Assessment